Global Diclofenac Sodium Enteric-coated Tablets Market Growth 2024-2030

Global Diclofenac Sodium Enteric-coated Tablets Market Growth 2024-2030

Product Code:1240225

Published Date: Nov 22,2024

Pages: 144

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Diclofenac Sodium Enteric-coated Tablets market size is predicted to grow from US$ 145 million in 2024 to US$ 207 million in 2030; it is expected to grow at a CAGR of 6.1% from 2024 to 2030.

Diclofenac sodium enteric-coated tablets are a nonsteroidal anti-inflammatory drug that is mainly used to relieve pain, reduce inflammation and reduce fever. The drug is slowly released in the small intestine to reduce irritation to the gastric mucosa, thereby reducing the risk of gastrointestinal side effects. Diclofenac sodium enteric-coated tablets are widely used in clinical practice to treat various pain and inflammatory diseases.

United States market for Diclofenac Sodium Enteric-coated Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Diclofenac Sodium Enteric-coated Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Diclofenac Sodium Enteric-coated Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Diclofenac Sodium Enteric-coated Tablets players cover Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd., Huizhou Daya Pharmaceutical Co., Ltd., Guangdong South China Pharmaceutical Group Co., Ltd., Henan Blueprint Pharmaceutical Co., Ltd., Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Diclofenac Sodium Enteric-coated Tablets Industry Forecast” looks at past sales and reviews total world Diclofenac Sodium Enteric-coated Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Diclofenac Sodium Enteric-coated Tablets sales for 2024 through 2030. With Diclofenac Sodium Enteric-coated Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diclofenac Sodium Enteric-coated Tablets industry.

This Insight Report provides a comprehensive analysis of the global Diclofenac Sodium Enteric-coated Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diclofenac Sodium Enteric-coated Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diclofenac Sodium Enteric-coated Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diclofenac Sodium Enteric-coated Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diclofenac Sodium Enteric-coated Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Diclofenac Sodium Enteric-coated Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    25mg
    50mg

Segmentation by Application:
    Hospital
    Clinic
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
    Huizhou Daya Pharmaceutical Co., Ltd.
    Guangdong South China Pharmaceutical Group Co., Ltd.
    Henan Blueprint Pharmaceutical Co., Ltd.
    Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd.
    Xinxiang Changle Pharmaceutical Co., Ltd.
    Ganmei (Guangdong) Pharmaceutical Co., Ltd.
    Jilin ASEAN Pharmaceutical Co., Ltd.
    Jiangxi Jurentang Pharmaceutical Co., Ltd.
    Foshan Shouxin Pharmaceutical Co., Ltd.
    Changchun Changhong Pharmaceutical Co., Ltd.
    Renhetang Pharmaceutical Co., Ltd.
    Jilin Guowen Pharmaceutical Co., Ltd.
    Livzon Group Livzon Pharmaceutical Factory
    Jilin Yinok Pharmaceutical Co., Ltd.
    Henan Baiquan Pharmaceutical Co., Ltd.
    Jilin Changheng Pharmaceutical Co., Ltd.
    Guangdong Rote Pharmaceutical Co., Ltd.
    Guangdong Bangmin Pharmaceutical Factory Co., Ltd.
    Changchun Changqing Pharmaceutical Group Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Diclofenac Sodium Enteric-coated Tablets market?
What factors are driving Diclofenac Sodium Enteric-coated Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diclofenac Sodium Enteric-coated Tablets market opportunities vary by end market size?
How does Diclofenac Sodium Enteric-coated Tablets break out by Type, by Application?